← Back to Search

Procedure

WACA for Atrial Fibrillation (WACAvsEWACA Trial)

N/A
Waitlist Available
Led By Mazda Biria, MD
Research Sponsored by Mosaic Life Care
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
All subjects with symptomatic persistent atrial fibrillation who are scheduled for clinically indicated ablation of AF.
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights

WACAvsEWACA Trial Summary

This study is evaluating whether a specific type of ablation may be more effective than another.

WACAvsEWACA Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

WACAvsEWACA Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
To evaluate the achievement of sinus rhythm in subjects undergoing ablation of atrial fibrillation using WACA compared to E-WACA.
Secondary outcome measures
ii. To compare the time to reoccurrence of atrial fibrillation, atrial flutter and/or atrial tachycardia in subjects undergoing ablation of atrial fibrillation using WACA compared to E-WACA.
Other outcome measures
iii. To assess the frequency of complications in subjects undergoing ablation of atrial fibrillation using WACA compare to E-WACA.

WACAvsEWACA Trial Design

2Treatment groups
Active Control
Group I: WACAActive Control1 Intervention
wide area circular ablation
Group II: EWACAActive Control1 Intervention
extra-wide area circular ablation

Find a Location

Who is running the clinical trial?

Mosaic Life CareLead Sponsor
1 Previous Clinical Trials
8 Total Patients Enrolled
Mazda Biria, MDPrincipal InvestigatorPhysician of Cardiology and Electrophysiology

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Circulation: Arrhythmia and ElectrophysiologyJournal
Left Atrial Posterior Wall Isolation Does Not Improve the Outcome of Circumferential Pulmonary Vein Ablation for Atrial Fibrillation
Tamborero, David, Lluís Mont, Antonio Berruezo, Maria Matiello, Begoña Benito, Marta Sitges, Barbara Vidal, et al.. 2009. “Left Atrial Posterior Wall Isolation Does Not Improve the Outcome of Circumferential Pulmonary Vein Ablation for Atrial Fibrillation”. Circulation: Arrhythmia and Electrophysiology. Ovid Technologies (Wolters Kluwer Health). doi:10.1161/circep.108.797944.
clinicaltrials.govStudy
Wide Area Circular Ablation Versus Extra-wide Area Circular Ablation in Persistent Atrial Fibrillation
Mazda Biria 2016. "Wide Area Circular Ablation Versus Extra-wide Area Circular Ablation in Persistent Atrial Fibrillation". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT02814136.
~17 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top